Key points are not available for this paper at this time.
Mitotic inhibition following treatment with eribulin and copanlisib by IHC in 3 eribulin-resistant PDX models
Guo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: